Volume 27, Issue 18
Heterocyclic Compounds
Full Access

ChemInform Abstract: Conformationally Constrained Analogues of Diacylglycerol. Part 12. Ultrapotent Protein Kinase C Ligands Based on a Chiral 4,4- Disubstituted Heptono-1,4-lactone Template.

J. LEE

J. LEE

Lab. Med. Chem., Dev. Ther. Program, Natl. Cancer Inst., NIH, Bethesda, MD 20892, USA

Search for more papers by this author
R. SHARMA

R. SHARMA

Lab. Med. Chem., Dev. Ther. Program, Natl. Cancer Inst., NIH, Bethesda, MD 20892, USA

Search for more papers by this author
S. WANG

S. WANG

Lab. Med. Chem., Dev. Ther. Program, Natl. Cancer Inst., NIH, Bethesda, MD 20892, USA

Search for more papers by this author
G. W. A. MILNE

G. W. A. MILNE

Lab. Med. Chem., Dev. Ther. Program, Natl. Cancer Inst., NIH, Bethesda, MD 20892, USA

Search for more papers by this author
N. E. LEWIN

N. E. LEWIN

Lab. Med. Chem., Dev. Ther. Program, Natl. Cancer Inst., NIH, Bethesda, MD 20892, USA

Search for more papers by this author
Z. SZALLASI

Z. SZALLASI

Lab. Med. Chem., Dev. Ther. Program, Natl. Cancer Inst., NIH, Bethesda, MD 20892, USA

Search for more papers by this author
P. M. BLUMBERG

P. M. BLUMBERG

Lab. Med. Chem., Dev. Ther. Program, Natl. Cancer Inst., NIH, Bethesda, MD 20892, USA

Search for more papers by this author
C. GEORGE

C. GEORGE

Lab. Med. Chem., Dev. Ther. Program, Natl. Cancer Inst., NIH, Bethesda, MD 20892, USA

Search for more papers by this author
V. E. MARQUEZ

V. E. MARQUEZ

Lab. Med. Chem., Dev. Ther. Program, Natl. Cancer Inst., NIH, Bethesda, MD 20892, USA

Search for more papers by this author
First published: April 30, 1996

Abstract

ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.

ChemInform Abstract

Conformationally constrained analogues of diacylglycerol (DAG) built on a 5-((acyloxy)methyl)-5-(hydroxymethyl)tetrahydro-2-furanone such as (VI) are shown previously to bind tightly to protein kinase Cα (PK-Cα) in a stereospecific manner. These compounds, however, racemize readily through rapid acyl migration and lose biological potency. In order to circumvent this problem, the “reversed ester” analogues (I)-(V) are designed as a new set of PK-C ligands. The reversed ester analogues are impervious to racemization, and their chemically distinct branches facilitate the enantiospecific syntheses of all targets. Conversion of the propanoyl branch into a propenoyl branch and functionalization of the propenoyl-branched compounds as . alpha.-alkylidene lactones produce stable compounds with equiv. ultrapotent binding affinities for PK-C ((II), (III), (IV)). The biological activity of the most potent agonist (IIIb) is evaluated further.

chemical structure image

    The full text of this article hosted at iucr.org is unavailable due to technical difficulties.